Hui Shao

Hui Shao currently works at YishengBio Co., Ltd., as President, Chief Executive Officer & Director, LakeShore Biopharma Co., Ltd., as Vice Chairman & President, and The New York Society of Security Analysts, Inc., as Member.
Dr. Shao also formerly worked at Liaoning Yisheng Biopharmaceutical Co. Ltd., as President, Chief Executive Officer & Director from 2018 to 2020, Yisheng Biopharma Co., Ltd., as President, Chief Executive Officer & Director from 2018 to 2020, Aoxing Pharmaceutical Co., Inc., as Independent Director from 2015 to 2016, Tongli Pharmaceuticals (USA), Inc., as Independent Director in 2011, Sohu.com, Inc., as Principal, Roche Pharmaceuticals, Inc., as Chief Scientist from 1997 to 2003, Mehta Partners LLC, as Research Analyst from 2003 to 2005, Aoxing Pharmaceutical Co., Inc., as Chief Financial Officer & Senior VP-Finance from 2007 to 2010, and Shanghai Five One Network Development Co., Ltd., as Vice President.
Dr. Shao received his doctorate degree in 1996 from the University of California San Diego, undergraduate degree in 1991 from the University of Science & Technology of China, and Masters Business Admin degree in 2003 from The Leonard N Stern School of Business.